STa peptide analogs for probing guanylyl cyclase C
Related Experiment Video
Updated: Jul 3, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Xiaobing Tian1, Allison M Michal, Peng Li
1Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Abstract:
Guanylyl cyclase C (GC-C), universally overexpressed on primary and metastatic colorectal carcinoma cells, is activated by endogenous ligands, guanylin, and uroguanylin, and by exogenous 18-residue heat-stable enterotoxins (STa) produced by diarrheagenic bacteria. Two 12-residue STa analogs with alternate combinations of two interlocked disulfide bonds, peptides 3 and 6, were synthesized by orthogonal solid phase synthesis routes. Peptides 3 and 6 bound GC-C with a rank order potency of STa > peptide 3 > peptide 6. Peptides 3 and 6 behaved as agonists in stimulating cGMP production. The results reveal that the toxic domain of STa can be reduced to 12 amino acids.
Insights
Researchers reduced the toxic domain of heat-stable enterotoxin (STa) to 12 amino acids. These STa analogs effectively bind and activate guanylyl cyclase C (GC-C), showing potential for colorectal cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Guanylyl cyclase C (GC-C) is overexpressed in colorectal cancer cells.
- GC-C is activated by endogenous ligands and bacterial heat-stable enterotoxins (STa).
Purpose of the Study:
- To synthesize and characterize shorter analogs of the STa toxin.
- To investigate the binding affinity and functional activity of these STa analogs on GC-C.
Main Methods:
- Orthogonal solid-phase synthesis was used to create two 12-residue STa analogs (peptides 3 and 6) with distinct disulfide bond configurations.
- Binding potency to GC-C was assessed, along with the ability to stimulate cyclic guanosine monophosphate (cGMP) production.
Main Results:
- Peptides 3 and 6 were successfully synthesized and demonstrated binding to GC-C.
- The rank order of binding potency was STa > peptide 3 > peptide 6.
- Both peptides 3 and 6 acted as agonists, stimulating cGMP production.
Conclusions:
- The toxic domain of STa can be significantly reduced to 12 amino acids while retaining GC-C binding and agonist activity.
- These findings suggest potential for developing targeted therapies for colorectal cancer based on modified STa structures.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Amplifying Signals via Second Messengers
cAMP-dependent Protein Kinase Pathways
G-protein Coupled Receptors
Activation and Inactivation of G Proteins

